Association of daily and on-demand tadalafil use with all-cause mortality and cardiovascular outcomes in men with erectile dysfunction and lower urinary tract symptoms: a propensity score-matched real-world cohort study
This propensity score-matched cohort study found that while both daily (5 mg) and on-demand (20 mg) tadalafil use were associated with significantly lower risks of all-cause mortality and cardiovascular events compared to non-use in men with erectile dysfunction or lower urinary tract symptoms, on-demand tadalafil 20 mg was linked to superior long-term survival outcomes compared to the daily regimen.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For many men, the ability to perform sexually and the ability to urinate without difficulty are two separate concerns, often treated by different doctors. Yet, in the body, these functions are deeply linked. Both rely on the health of blood vessels and the smooth flow of blood through tissues. When these systems begin to falter, it often signals that the cardiovascular system—the heart and the network of vessels that feed the entire body—is under stress. In fact, trouble with erections or urinary flow can appear years before a heart attack or stroke, acting as an early warning sign of broader vascular disease. Because of this connection, doctors have long wondered if the medications used to treat these specific symptoms might also offer protection for the heart, perhaps by improving the health of blood vessels in a way that goes beyond just fixing the immediate problem.
A large study recently examined this possibility by looking at a popular medication called tadalafil, which is prescribed for erectile dysfunction and urinary issues. This drug is unique because it can be taken in two different ways: a small dose every day or a larger dose only when needed. Researchers wanted to know if taking the drug daily offered different long-term benefits than taking it only occasionally, and whether using the drug at all was better for survival than not using it. By analyzing the medical records of more than one million men, the study found that men who took tadalafil, regardless of the dosing schedule, were significantly less likely to die from any cause or develop serious heart problems compared to those who did not take the medication. Furthermore, when comparing the two ways of taking the drug, the data suggested that men who took the larger, on-demand dose lived longer and remained free from heart disease for a longer time than those who took the daily low dose.
The researchers conducted this investigation using a massive database of de-identified electronic health records from hospitals across the United States. They focused on men aged forty and older who had been diagnosed with erectile dysfunction or urinary symptoms related to an enlarged prostate. To ensure a fair comparison, the team carefully selected groups of men who were similar in age, race, and pre-existing health conditions like high blood pressure or diabetes. They compared men who received tadalafil against a huge group of men with the same conditions who never received any medication for these issues. They also directly compared the men who took the daily five-milligram dose against those who took the twenty-milligram dose on an as-needed basis. The study followed these patients for up to fourteen years to see who experienced major health events, such as heart failure, stroke, or death.
The results showed a clear pattern. Men who took tadalafil, whether daily or on-demand, had a much lower risk of dying from any cause compared to men who did not take the drug. They were also less likely to suffer from heart failure, strokes, or blocked arteries. This finding supports the idea that the medication may do more than just relieve symptoms; it might help protect the heart and blood vessels over the long term. The study suggests that the drug works by improving the function of the inner lining of blood vessels, which helps them relax and flow more easily, potentially slowing down the damage that leads to heart disease.
When the researchers looked directly at the two different dosing strategies, a subtle but significant difference emerged. While both groups did better than those who took no medication, the men taking the twenty-milligram on-demand dose appeared to have better long-term survival outcomes than those taking the five-milligram daily dose. The data indicated that the on-demand group lived longer and stayed free from cardiovascular disease for a longer period. However, the authors are careful to note that this does not prove the higher dose is medically superior. It is possible that men prescribed the on-demand dose were generally healthier to begin with, perhaps having better sexual activity and fewer hidden health issues that the database did not capture. The daily dose is often prescribed for men with more bothersome urinary symptoms, which might be linked to other health complications.
Because this study was based on past medical records rather than a controlled experiment where patients were randomly assigned to groups, the researchers cannot say for certain that the drug caused the improved survival rates. The findings show a strong association, but they do not rule out the possibility that other factors influenced the results. The study highlights that while tadalafil is effective for its intended purposes, it may also be linked to better heart health, but it is not a proven treatment for preventing heart disease on its own. The authors conclude that while the results are promising and suggest a potential benefit for the heart, more rigorous testing is needed to confirm whether the specific way the drug is taken truly changes long-term health outcomes. Until then, the decision to use the medication should remain a personal choice between a patient and their doctor, based on symptoms and individual health needs.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.